Sadhana Nitro Chem secures exchange approval for preferential equity issue
Sadhana Nitro Chem Limited secured in-principle approvals from BSE and NSE on July 27-28, 2026, for a preferential issue of 6.75 crore equity shares at ₹2.06 each. The issue targets non-promoter investors under SEBI LODR Regulation 28(1). The company must enforce strict trading restrictions on allottees and file for listing within twenty days of allotment to avoid regulatory penalties.

*this image is generated using AI for illustrative purposes only.
Sadhana Nitro Chem Limited has received in-principle approvals from the Bombay Stock Exchange (BSE) and the National Stock Exchange of India Limited (NSE) for a proposed preferential issue of equity shares. The company intends to issue 6,75,00,000 equity shares of Re. 1/- each at a price not less than ₹2.06/- each to non-promoter investors. This capital raise is structured under Regulation 28(1) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, marking a significant step in the company’s fundraising efforts.
The approvals were granted on July 27, 2026, by the NSE and subsequently acknowledged by the BSE. The intimation was filed on July 28, 2026, by Nitin Rameshchandra Jani, Company Secretary of Sadhana Nitro Chem Limited. The regulatory nod allows the company to proceed with the issue subject to fulfilling specific compliance requirements outlined by both exchanges and statutory authorities.
| Parameter | Detail |
|---|---|
| Number of Shares | 6,75,00,000 |
| Face Value | Re. 1/- |
| Issue Price | Not less than ₹2.06/- |
| Allottees | Non-Promoters |
| Regulatory Basis | Regulation 28(1), SEBI LODR 2015 |
Both exchanges have emphasized the need for strengthened internal controls to monitor trades executed by proposed allottees. The company is advised to obtain undertakings from allottees confirming they will not engage in intra-day trading or sell the scrip until the allotment date, as required under Chapter V of the SEBI (Issue of Capital and Disclosure Requirements) Regulations, 2018. The onus of verifying these undertakings lies solely with the issuer company.
Non-compliance with these trading restrictions could impact the listing of the shares. The exchanges reserved the right to withdraw the in-principle approval if submitted information is found to be incomplete, incorrect, or misleading. Additionally, the company must obtain all necessary statutory approvals from bodies including the Reserve Bank of India and the Ministry of Corporate Affairs before proceeding.
What the Numbers Show
The pricing of the shares at not less than ₹2.06/- each indicates a premium over the face value of Re. 1/-, suggesting investor confidence in the company’s valuation. The substantial size of the issue—6.75 crore shares—implies a significant capital infusion aimed at funding operational expansion or debt reduction. However, the strict adherence to SEBI ICDR regulations regarding lock-in periods and trading restrictions highlights the regulatory scrutiny associated with preferential issues to non-promoters.
The company is required to file a listing application within twenty days from the date of allotment, as per Schedule XIX – Para (2) of the ICDR Regulations and SEBI circular no. SEBI/HO/CFD/PoD-2/P/CIR/2023/00094 dated June 21, 2023. Failure to comply with this timeline will attract fines as specified in the same circular. The final listing remains contingent upon the completion of all post-issue formalities and payment of applicable fees to the exchanges.
Historical Stock Returns for Sadhana Nitrochem
| 1 Day | 5 Days | 1 Month | 6 Months | 1 Year | 5 Years |
|---|---|---|---|---|---|
| -1.12% | +0.76% | -8.90% | +67.30% | +34.34% | -88.19% |
How will the capital raised from this preferential issue be allocated between debt reduction and operational expansion?
What impact might the issuance of 6.75 crore shares have on existing shareholders' equity and earnings per share (EPS)?
Which specific non-promoter investors have been identified for the allotment, and what is their strategic rationale for investing in Sadhana Nitro Chem?


































